Table 5.

Univariable cox regression analysis for composite secondary endpoint.

Characteristic	Hazard Ratio (95% CI)	p Value
Age	1.01 (1.00–1.03)	0.16
Sex [Female]	0.61 (0.40–0.92)	0.01
DCB/DES use [DES]	0.84 (0.62–1.13)	0.24
Frailty score	1.08 (0.94–1.25)	0.27
Dyslipidaemia	1.12 (0.82–1.52)	0.48
Hypertension	1.01 (0.75–1.37)	0.93
Cerebrovascular event	1.48 (0.86–2.55)	0.16
Myocardial infarction	1.14 (0.78–1.67)	0.49
Coronary artery bypass grafting	1.02 (0.59–1.76)	0.95
Heart failure	1.33 (0.55–3.24)	0.53
Chronic obstructive pulmonary disease	0.67 (0.30–1.51)	0.33
Diabetes mellitus	1.36 (0.98–1.86)	0.06
Previous/current smoker	0.73 (0.54–0.99)	0.04
Creatinine	1.00 (1.00–1.01)	0.12
Multivessel disease	1.04 (0.66–1.65)	0.85
Bifurcation lesion	1.19 (0.85–1.65)	0.85
Heavy calcification	1.76 (1.29–2.39)	<0.001
Diffuse disease	1.14 (0.82–1.59)	0.42
Severe tortuosity	1.06 (0.71–1.58)	0.77
Vessel diameter	1.00 (0.78–1.28)	>0.99
Lesion length	1.00 (0.99–1.01)	0.66

Propensity score matching revealed the same results for all analyses and is included in the Supplementary Materials (Supplementary Figures S4–S7). A statistically significant p-value is highlighted in bold.